Search results
Athersys (ATHX) Down as Ischemic Stroke Study Fails to Meet Goal
Zacks via Yahoo Finance· 2 years agoWhile a mid-stage/late-stage study evaluating Athersys' (ATHX) stem cell treatment for ischemic...
Athersys (NASDAQ:ATHX) adds US$19m to market cap in the past 7 days, though investors from three...
Simply Wall St. via Yahoo Finance· 2 years agoIt's nice to see the Athersys, Inc. (NASDAQ:ATHX) share price up 24% in a week. But that is meagre...
News Flash: One Analyst Just Made An Incredible Upgrade To Their Athersys, Inc. (NASDAQ:ATHX)...
Simply Wall St. via Yahoo Finance· 2 years agoShareholders in Athersys, Inc. (NASDAQ:ATHX) may be thrilled to learn that the covering analyst has...
Athersys, Inc. (NASDAQ:ATHX) Q3 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoAthersys, Inc. (NASDAQ:ATHX) Q3 2022 Earnings Call Transcript November 15, 2022 Athersys, Inc. beats...
Radiation Countermeasure Study Data For U.S. Defense Department Gets First Readout
Benzinga via Yahoo Finance· 2 years agoAthersys Inc (NASDAQ: ATHX) has announced the results of a radiation countermeasure study that...
Athersys-Partnered Japanese Ischemic Stroke Study Disappoints, Shares Plunge
Benzinga via Yahoo Finance· 2 years agoAthersys Inc's (NASDAQ: ATHX) partner, Healios K.K. has reported topline results for its Japan...
Is Athersys Inc (ATHX) Significantly Overvalued?
GuruFocus.com via Yahoo Finance· 8 months agoToday, we delve into the financials of Athersys Inc (NASDAQ:ATHX), a biotechnology company with a daily gain of 12.75%. Despite this gain, the company...
7 Biotech Stocks With Key Catalysts for May
InvestorPlace via Yahoo Finance· 2 years agoBiotech stocks have been through an extended lean patch, making them ideal candidates for a strong rebound. Verrica (VRCA): Approval of its viral skin...
Are Longevity Stocks the Next Trillion-Dollar Industry? 3 Anti-Aging Picks
InvestorPlace via Yahoo Finance· 6 months agoLongevity stocks have started to come on many investors’ radars. These companies come with the...
The Three Best Anti-Aging Stocks to Buy in September
InvestorPlace via Yahoo Finance· 2 years agoAnti-aging stocks have not proven immune to poor market conditions that have plagued the broader biotech industry. The biotech industry remains hampered...
